Search
BioCryst Pharmaceuticals Inc
BCRXAdd to Watchlist
9.140USD
+0.150+1.67%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
1.92BMarket Cap
LossP/E TTM
BioCryst Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-22The current valuation score of BioCryst Pharmaceuticals Inc is 8.66, ranking 107 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.31, which is -248.27% below the recent high of 7.87 and -3346.37% above the recent low of -182.87.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
